1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    


























































































































    Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleSpine

  
      

  
      
Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis
  
    	
A.F. Marliani, V. Clementi, L. Albini Riccioli, R. Agati, M. Carpenzano, F. Salvi and M. Leonardi

  
    	
American Journal of Neuroradiology January 2010,  31 (1) 180-184; DOI: https://doi.org/10.3174/ajnr.A1738 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. He  J, 
    2. Inglese  M, 
    3. Li  BS, 
    4. et al
    . Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging—initial experience. Radiology 2005; 234: 211–17
    PubMedWeb of Science
  2. 2.↵


    1. Cucurella  MG, 
    2. Rovira  A, 
    3. Río  J, 
    4. et al
    . Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis. NMR Biomed 2000; 13: 57–63
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Sijens  PE, 
    2. Mostert  JP, 
    3. Oudkerk  M, 
    4. et al
    . 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol 2006; 16: 489–95
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. Adalsteinsson  E, 
    2. Langer-Gould  A, 
    3. Homer  RJ, 
    4. et al
    . Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2003; 24: 1941–45
    Abstract/FREE Full Text
  5. 5.↵


    1. Narayanan  PA, 
    2. Doyle  TJ, 
    3. Lai  D, 
    4. et al
    . Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56–71
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. Nelson  F, 
    2. Poonawalla  AH, 
    3. Hou  P, 
    4. et al
    . Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645–49
    Abstract/FREE Full Text
  7. 7.↵


    1. Chard  DT, 
    2. Griffin  CM, 
    3. McLean  MA, 
    4. et al
    . Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342–52
    Abstract/FREE Full Text
  8. 8.↵


    1. Bozzali  M, 
    2. Cercignani  M, 
    3. Sormani  MP, 
    4. et al
    . Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol 2002; 23: 985–88
    Abstract/FREE Full Text
  9. 9.↵


    1. Dehmeshki  J, 
    2. Chard  DT, 
    3. Leary  SM, 
    4. et al
    . The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol 2003; 250: 67–74
    CrossRefPubMedWeb of Science
  10. 10.↵


    1. Kapeller  P, 
    2. McLean  MA, 
    3. Griffin  CM, 
    4. et al
    . Preliminary evidence for neuronal damage in cortical grey matter and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 2001; 248: 131–38
    CrossRefPubMedWeb of Science
  11. 11.↵


    1. Narayanan  PA
    . Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging 2005; 15: 46S 57S
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. Miki  Y, 
    2. Grossman  RI, 
    3. Udupa  JK, 
    4. et al
    . Relapsing-remitting multiple sclerosis: longitudinal analysis of MR images—lack of correlation between changes in T2 lesion volume and clinical findings. Radiology 1999; 213: 395–99
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. Zivadinov  R, 
    2. Leist  TP
    . Clinical-magnetic resonance imaging correlations in multiple sclerosis. J Neuroimaging 2005; 15: 10S–21S
    CrossRefPubMedWeb of Science
  14. 14.↵


    1. Brex  PA, 
    2. Ciccarelli  O, 
    3. O'Riordan  JI, 
    4. et al
    . A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 2002; 346: 158–64
    CrossRefPubMedWeb of Science
  15. 15.↵


    1. Barkhof  F
    . The clinico-pathological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002; 15: 239–45
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. Wolinsky  JS, 
    2. Narayana  PA, 
    3. Fenstermacher  MJ
    . Proton magnetic resonance spectroscopy in multiple sclerosis. Neurology 1990; 40: 1764–69
    Abstract/FREE Full Text
  17. 17.↵


    1. Inglese  M, 
    2. Li  BS, 
    3. Rusinek  H, 
    4. et al
    . Diffusely elevated cerebral choline and creatine in relapsing-remitting multiple sclerosis. Magn Reson Med 2003; 50: 190–95
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. De Stefano  N, 
    2. Narayanan  S, 
    3. Francis  GS, 
    4. et al
    . Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 2001; 58: 65–70
    CrossRefPubMedWeb of Science
  19. 19.↵


    1. De Stefano  N, 
    2. Matthews  PM, 
    3. Fu  L, 
    4. et al
    . Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis: results of a longitudinal magnetic resonance spectroscopy study. Brain 1998; 121: 1469–77
    Abstract/FREE Full Text
  20. 20.↵


    1. Kapeller  P, 
    2. Brex  PA, 
    3. Chard  D, 
    4. et al
    . Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 2002; 8: 207–10
    Abstract/FREE Full Text
  21. 21.↵


    1. Kendi  AT, 
    2. Tan  FU, 
    3. Kendi  M, 
    4. et al
    . MR spectroscopy of cervical spinal cord in patients with multiple sclerosis. Neuroradiology 2004; 46: 764–69
    CrossRefPubMedWeb of Science
  22. 22.↵


    1. Blamire  AM, 
    2. Cader  S, 
    3. Lee  M, 
    4. et al
    . Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy. Magn Reson Med 2007; 58: 880–85
    CrossRefPubMedWeb of Science
  23. 23.↵


    1. Henning  A, 
    2. Schär  M, 
    3. Kollias  SS, 
    4. et al
    . Quantitative magnetic resonance spectroscopy in the entire human cervical spinal cord and beyond at 3T. Magn Reson Med 2008; 59: 1250–58
    CrossRefPubMed
  24. 24.↵


    1. Cooke  F, 
    2. Blamire  AM, 
    3. Korlpara  LP, 
    4. et al
    . Proton spectroscopy of the motor pathway in patients with spinocerebellar ataxia (SCA). In: Proceedings of the 13th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Miami Beach, FL. May 7–13, 2005: 1227
  25. 25.↵


    1. Dydak  U, 
    2. Kollias  SS, 
    3. Schär  M, 
    4. et al
    . MR spectroscopy in different regions of the spinal cord and in spinal cord tumors. In: Proceedings of the 13th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Miami Beach, FL. May 7–13, 2005: 813
  26. 26.↵


    1. Ciccarelli  O, 
    2. Wheeler-Kingshott  CA, 
    3. McLean  MA, 
    4. et al
    . Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis. Brain 2007; 130: 2220–31
    Abstract/FREE Full Text
  27. 27.↵


    1. Marliani  AF, 
    2. Clementi  V, 
    3. Albini-Riccioli  L, 
    4. et al
    . Quantitative proton magnetic resonance spectroscopy of the human cervical spinal cord at 3 Tesla. Magn Reson Med 2007; 57: 160–63
    CrossRefPubMedWeb of Science
  28. 28.↵


    1. McDonald  WI, 
    2. Compston  A, 
    3. Edan  G, 
    4. et al
    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121–27
    CrossRefPubMedWeb of Science
  29. 29.↵


    1. Tran  TK, 
    2. Vigneron  DB, 
    3. Sailasuta  N, 
    4. et al
    . Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000; 43: 23–33
    CrossRefPubMedWeb of Science
  30. 30.↵


    1. Cooke  FJ, 
    2. Blamire  AM, 
    3. Manners  DN, 
    4. et al
    . Quantitative proton magnetic resonance spectroscopy of the cervical spinal cord. Magn Reson Med 2004; 51: 1122–28
    CrossRefPubMed
  31. 31.↵


    1. Provencher  SW.
    . Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672–79
    CrossRefPubMedWeb of Science
  32. 32.↵


    1. Gomez-Anson  B, 
    2. MacManus  DG, 
    3. Parker  GJM, 
    4. et al
    . In vivo 1H-magnetic resonance spectroscopy of the spinal cord in humans. Neuroradiology 2000; 42: 515–17
    CrossRefPubMedWeb of Science
  33. 33.↵


    1. Dubey  P, 
    2. Smith  M, 
    3. Bonekamp  D, 
    4. et al
    . Proton MR spectroscopic imaging of the human cervical spine at 3 Tesla. In: Proceedings of the 13th Annual Meeting of the International Society for Magnetic Resonance in Medicine, Miami Beach, FL. May 7–13, 2005: 812
  34. 34.↵


    1. Edden  RA, 
    2. Bonekamp  D, 
    3. Smith  MA, 
    4. et al
    . Proton MR spectroscopic imaging of the medulla and cervical spinal cord. J Magn Reson Imaging 2007; 26: 1101–05
    CrossRefPubMed
  35. 35.↵


    1. Bot  JC, 
    2. Barkhof  F.
    . Spinal-cord MRI in multiple sclerosis: conventional and nonconventional MR techniques. Neuroimaging Clin N Am 2009; 19: 81–99
    CrossRefPubMedWeb of Science
  36. 36.↵


    1. Thorpe  JW, 
    2. Kidd  D, 
    3. Moseley  IF, 
    4. et al
    . Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis.  Neurology 1996; 46: 373–78
    Abstract/FREE Full Text
  37. 37.↵


    1. Kidd  D, 
    2. Thorpe  JW, 
    3. Kendall  BE, 
    4. et al
    . MRI dynamics of brain and spinal cord in progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 1996; 60: 15–19
    Abstract/FREE Full Text
  38. 38.↵


    1. Bot  JC, 
    2. Barkhof  F, 
    3. Polman  CH, 
    4. et al
    . Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 2004; 62: 226–33
    Abstract/FREE Full Text
  39. 39.↵


    1. Bjartmar  C, 
    2. Kidd  G, 
    3. Mork  S, 
    4. et al
    . Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann Neurol 2000; 48: 893–901
    CrossRefPubMedWeb of Science
  40. 40.↵


    1. Ruiz-Pena  JL, 
    2. Pinero  P, 
    3. Sellers  G, 
    4. et al
    . Magnetic resonance spectroscopy of normal appearing white matter in early relapsing-remitting multiple sclerosis: correlations between disability and spectroscopy. BMC Neurol 2004; 4: 8
    CrossRefPubMed
  41. 41.↵


    1. Bot  JC, 
    2. Blezer  EL, 
    3. Kamphorst  W, 
    4. et al
    . The spinal cord in multiple sclerosis: relationship of high-spatial-resolution quantitative MR imaging findings to histopathologic results. Radiology 2004; 233: 531–40
    PubMedWeb of Science
  42. 42.↵


    1. Bergers  E, 
    2. Bot  JC, 
    3. De Groot  CJ, 
    4. et al
    . Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesions. Neurology 2002; 59: 1766–71
    Abstract/FREE Full Text
  43. 43.↵


    1. Rashid  W, 
    2. Davies  GR, 
    3. Chard  DT, 
    4. et al
    . Increasing cord atrophy in early relapsing-remitting multiple sclerosis: a 3 year study. J Neurol Neurosurg Psychiatry 2006; 77: 51–55
    Abstract/FREE Full Text
  44. 44.↵


    1. Nijeholt  G, 
    2. van Walderveen  MA, 
    3. Castelijns  JA, 
    4. et al
    . Brain and spinal cord abnormalities in multiple sclerosis: correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998; 121: 687–97
    Abstract/FREE Full Text
  45. 45.↵


    1. Stevenson  VL, 
    2. Leary  SM, 
    3. Losseff  NA, 
    4. et al
    . Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998; 51: 234–38
    Abstract/FREE Full Text
  46. 46.↵


    1. Riccioli  LA, 
    2. Marliani  AF, 
    3. Clementi  V, 
    4. et al
    . Evolutive study of relapsing-remitting multiple sclerosis with cervical proton magnetic resonance spectroscopy: a case report. Neuroradiol J 2008; 21: 511–17
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Quantitative Cervical Spinal Cord 3T Proton MR Spectroscopy in Multiple Sclerosis
  
    	
A.F. Marliani, V. Clementi, L. Albini Riccioli, R. Agati, M. Carpenzano, F. Salvi, M. Leonardi

  
    	
American Journal of Neuroradiology Jan 2010, 31 (1) 180-184; DOI: 10.3174/ajnr.A1738 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement